Danaher | DHR - Ebitda





Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Agilent USD 456M 84M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 116.71M 13.29M 2026-03
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Bruker USD 110M 101.6M 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
ESCO Technologies USD 76.38M 11.33M 2026-03
Fortive USD 314M 25.3M 2026-03
Henry Schein USD 289M 2M 2026-03
Illumina USD 469M 137M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Keysight Technologies USD 519M 71M 2025-12
Laboratory Of America USD 605.6M 17.5M 2026-03
Medtronic USD 2.81B 119M 2026-03
Mettler Toledo International USD 278.99M 100.24M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 108.7M 44.6M 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Roper Industries USD 858.2M 39.2M 2025-12
Stryker USD 1.57B 618M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12